RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the name of an RNA virus that has changed the equations of the world since December 2019. More than 3.8 million people have been death caused by coronavirus [1,2].
The rate of evolution in SARS-CoV-2 is slow in comparison with other RNA viruses, but during this time, due to the high rate of spread among the people, it has been able to find significant genetic diversity and it is the main reason of the emergence of its several variants. B.1.1.7 (Alpha), B.1.351 (Beta), and P.1 (Gamma) are the different variant types of SARS-CoV-2 that were discovered in in Southeastern England, South Africa, and Germany, respectively. B1.617.1, B.1.617.2, and B.1.617.3 are the primary subtypes of the B1.617 lineage. Each of these variants has mutations in the N-terminal domain (NTD) and receptor-binding domain of the SARS-CoV-2 spike protein, which may help them evade the immune system. The B.1.617.2 (Delta) variant was emerged in the state of Maharashtra in late 2020 and has outspreaded from India, and it has been discovered in many countries [3].
The reports regarding Delta variant are not

참고문헌 (Reference)

1 Chia PY, "Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study" Cold Spring Harbor Laboratory

2 Sheikh A, "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness" 397 : 2461-2462, 2021

3 Planas D, "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization" 596 : 276-280, 2021

4 Moazzami B, "Is computed tomography necessary for the diagnosis of coronavirus disease(COVID–19)in all suspected patients? : a case series" 28 : 187-193, 2021

5 Pouwels KB, "Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK" Cold Spring Harbor Laboratory

6 Garcia LF, "Immune response, inflammation, and the clinical spectrum of COVID-19" 11 : 1441-, 2020

7 Lopez Bernal J, "Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant" 385 : 585-594, 2021

8 Moazzami B, "Does endometriosis increase susceptibility to COVID-19 infections? : a case-control study in women of reproductive age" 21 : 119-, 2021

9 Tada T, "Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants" Cold Spring Harbor Laboratory

10 Iacobucci G, "COVID-19: are high rates of B.1.617.2 linked to vaccine hesitancy?" 373 : n1345-, 2021